September 2022:  Phase I and II Pneumococcal and Polio Vaccine Studies

Through a partner CRO supporting PATH (previously known as the Program for Appropriate Technology in Health), an international global health organization, Integrum Scientific provides clinical project management services for Phase I and II pneumococcal and polio vaccine studies.